1
Characterisation of Heart Involvement in Fabry Disease With T1 Mapping
Condition(s):Fabry DiseaseLast Updated:January 13, 2021Recruiting
Diagnostic Test: T1 Mapping: 49 Clinical Trials, Page 1 of 5
Hide Studies Not Open or Pending
2
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
Condition(s):NAFLD; Heart Failure; Valvular Disease; Coronary DiseaseLast Updated:January 7, 2020Not yet recruiting
3
Fluid Status and T1-mapping by CMR
Condition(s):Heart Diseases; Heart Failure; Valvular Heart DiseaseLast Updated:August 14, 2019Recruiting
4
Association of T1-mapping and LV Strain Analysis by CMR
Condition(s):Myocardial FibrosisLast Updated:March 16, 2020Recruiting
5
Decreased T1 Times and Impaired Myocardial Contractility in Anabolic Androgenic Steroids Users
Condition(s):Focal FibrosisLast Updated:March 5, 2019Completed
6
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Condition(s):Myocarditis; Heart Failure; Myocardial FibrosisLast Updated:June 23, 2020Recruiting
7
Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI
Condition(s):Liver Fibrosis; CirrhosisLast Updated:June 6, 2017Enrolling by invitation
8
Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)
Condition(s):Nonalcoholic SteatohepatitisLast Updated:May 16, 2019Completed
9
Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
Condition(s):Cardiotoxicity; Osteosarcoma; Myocardial Injury; Chemotherapy Induced Systolic Dysfunction; Doxorubicin Induced CardiomyopathyLast Updated:July 8, 2020Recruiting
10
Effect of Migalastat on Cardiac Involvement in Fabry Disease
Condition(s):Fabry Disease; Heart DiseasesLast Updated:October 22, 2020Active, not recruiting